Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: A case-control study.

Neuroscience letters - 1 Apr 2021

Xu Lifei, Dong Qiuping, Xu Liben, Zou Wei, Li Hui

Abstract excerpt

Monocyte chemoattractant protein-1 (MCP-1) is reported to associate with the severity and development of Alzheimer's disease (AD). While a few studies have examined the association between the MCP-1 A-2518 G polymorphism and AD risk, no Chinese study has undertaken a study of this association. Therefore, a case-control study with 212 AD cases and 268 controls was designed in Chinese participants. Logistic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alzheimer Disease
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemokine CCL2

Share to Genetic Association Studies

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 33577998
DOI: 10.1016/j.neulet.2021.135710

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: A case-control study.PMID 33577998Read ↗

MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.Semantic proximity Read ↗

Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.Semantic proximity Read ↗

No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.Semantic proximity Read ↗

Correlations of MCP-1 -2518A>G polymorphism and serum levels with cerebral infarction risk: a meta-analysis.Semantic proximity Read ↗

MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels.Semantic proximity Read ↗

Blood levels of MCP-1 modulate the genetic risks of Alzheimer's disease mediated by HLA-DRB1 and APOE for Alzheimer's disease.Semantic proximity Read ↗

Interleukin-8 gene polymorphism -251T>A contributes to Alzheimer's disease susceptibility.Semantic proximity Read ↗

Monocyte chemoattractant protein 1-2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population.Semantic proximity Read ↗

The association between the monocyte Chemoattractant protein-1-2518A/G polymorphism and the risk of tuberculosis in the Chinese population: A meta-analysis and systematic review.Semantic proximity Read ↗

Association of monocyte chemoattractant protein-1 (MCP-1)-2518A>G polymorphism with susceptibility to coronary artery disease: a meta-analysis.Semantic proximity Read ↗

The associations between the MCP-1 -2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals.Semantic proximity Read ↗

Association of MCP-1-2518A/G polymorphism with susceptibility to autoimmune diseases: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.